These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 19522957)
1. Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: a single center experience. Styron JF; Jois-Bilowich P; Tallman T; Emerman C; Starling RC; Frank Peacock W Congest Heart Fail; 2009; 15(3):103-7. PubMed ID: 19522957 [TBL] [Abstract][Full Text] [Related]
2. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
3. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment. Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693 [TBL] [Abstract][Full Text] [Related]
4. Nesiritide in the initial management of acute decompensated congestive heart failure. Sakr A; Hahn P; Donohue T; Ghantous A Conn Med; 2008 Oct; 72(9):517-23. PubMed ID: 18833867 [TBL] [Abstract][Full Text] [Related]
5. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441 [TBL] [Abstract][Full Text] [Related]
6. Effect of nesiritide on renal function in patients admitted for decompensated heart failure. Arora S; Clarke K; Srinivasan V; Gradman A QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392 [TBL] [Abstract][Full Text] [Related]
14. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Emerman CL Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696 [TBL] [Abstract][Full Text] [Related]
15. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247 [TBL] [Abstract][Full Text] [Related]
16. Short and long-term mortality with nesiritide. Arora RR; Venkatesh PK; Molnar J Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057 [TBL] [Abstract][Full Text] [Related]
17. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Chow SL; Peng JT; Okamoto MP; Heywood JT Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662 [TBL] [Abstract][Full Text] [Related]
18. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696 [TBL] [Abstract][Full Text] [Related]
19. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure. Aronson D; Burger AJ Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Emerman CL Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]